دورية أكاديمية

Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group

التفاصيل البيبلوغرافية
العنوان: Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
المؤلفون: Nielsen, Lene KongsgaardAff1, Aff2, Aff3, IDs41687024006912_cor1, Schjesvold, FredrikAff4, Aff5, Möller, SörenAff6, Aff7, Guldbrandsen, Nina, Hansson, Markus, Remes, Kari, Peceliunas, Valdas, Abildgaard, NielsAff1, Aff3, Aff6, Gregersen, Henrik, King, Madeleine T.Aff1, Aff12
المصدر: Journal of Patient-Reported Outcomes. 8(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:25098020
DOI:10.1186/s41687-024-00691-2